XOMA Corp (XOMA):企業の財務・戦略的SWOT分析

◆英語タイトル:XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81739FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

XOMA Corp (XOMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

XOMA Corp (Xoma), formerly Xoma Ltd, is a biopharmaceutical company. It develops antibody-based therapeutics. Its lead product, Gevokizumab is a monoclonal antibody used for the treatment of a wide variety of inflammatory diseases and other diseases. Its other pipeline products include RZ358, XMetA, X213 (formerly LFA 102) and PTH1R. XOMA X358 is a human negative allosteric modulating insulin receptor antibody; X213 is an allosteric inhibitor of prolactin action. Xoma has a developed proprietary antibody platform, optimization and development technologies, comprising ADAPT, ModulX and OptimX. It operates through its subsidiaries in Bermuda, Ireland and the US. Xoma is headquartered in Berkeley, California, the US.

XOMA Corp Key Recent Developments

Mar 22,2021: XOMA Announces Approval of First Preferred Stock Dividend
Mar 10,2021: XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights
Nov 05,2020: XOMA highlights recent royalty asset portfolio developments and reports third quarter 2020 financial results
Aug 06,2020: XOMA reports second quarter 2020 financial results
Jul 02,2020: XOMA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangement of certain officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
XOMA Corp – Key Facts
XOMA Corp – Key Employees
XOMA Corp – Key Employee Biographies
XOMA Corp – Major Products and Services
XOMA Corp – History
XOMA Corp – Company Statement
XOMA Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
XOMA Corp – Business Description
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: United States
Performance
XOMA Corp – Corporate Strategy
XOMA Corp – SWOT Analysis
SWOT Analysis – Overview
XOMA Corp – Strengths
XOMA Corp – Weaknesses
XOMA Corp – Opportunities
XOMA Corp – Threats
XOMA Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
XOMA Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 10, 2021: XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights
Nov 05, 2020: XOMA highlights recent royalty asset portfolio developments and reports third quarter 2020 financial results
Aug 06, 2020: XOMA reports second quarter 2020 financial results
Jul 02, 2020: XOMA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangement of certain officers
Jul 01, 2020: XOMA announces Natasha Hernday joins its Board of Directors
Mar 10, 2020: XOMA reports fourth quarter and full-year 2019 financial results and operating highlights
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
XOMA Corp, Key Facts
XOMA Corp, Key Employees
XOMA Corp, Key Employee Biographies
XOMA Corp, Major Products and Services
XOMA Corp, History
XOMA Corp, Subsidiaries
XOMA Corp, Key Competitors
XOMA Corp, Ratios based on current share price
XOMA Corp, Annual Ratios
XOMA Corp, Annual Ratios (Cont...1)
XOMA Corp, Interim Ratios
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
XOMA Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
XOMA Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[XOMA Corp (XOMA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PricewaterhouseCoopers LLP (UK):企業の戦略的SWOT分析
    PricewaterhouseCoopers LLP (UK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Saputo Dairy UK Ltd:企業の戦略的SWOT分析
    Saputo Dairy UK Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Haverty Furniture Companies, Inc. (HVT):企業の財務・戦略的SWOT分析
    Haverty Furniture Companies, Inc. (HVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Benitec Biopharma Ltd (BLT):医療機器:M&Aディール及び事業提携情報
    Summary Benitec Biopharma Ltd (Benitec) is a clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based th …
  • Integreon Inc:企業の戦略的SWOT分析
    Integreon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Publix Super Markets Inc:企業の戦略的SWOT分析
    Publix Super Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Abraxas Petroleum Corp (AXAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mid-Continent, Rocky Mountain, Gulf Coast and Permian Basin regions of the US. Abraxas’s Permian basin …
  • Aston Martin Lagonda Global Holdings Plc (AML):企業の財務・戦略的SWOT分析
    Aston Martin Lagonda Global Holdings Plc (AML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Paychex, Inc. (PAYX):企業の財務・戦略的SWOT分析
    Paychex, Inc. (PAYX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mondi plc (MNDI):企業の財務・戦略的SWOT分析
    Mondi plc (MNDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vedanta Resources Plc:企業のM&A・事業提携・投資動向
    Vedanta Resources Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Resources Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • CSR Ltd:企業の戦略・SWOT・財務情報
    CSR Ltd - Strategy, SWOT and Corporate Finance Report Summary CSR Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • AgaMatrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary AgaMatrix Inc (AgaMatrix) is a medical device company that offers biosensors and blood glucose monitors. The company designs, develops and manufactures diabetes products for pharmaceutical companies. Its products comprise Jazz Wireless 2, blood glucose monitors, Connected Health and AgaMatri …
  • Great Plains Energy Incorporated:企業の戦略・SWOT・財務情報
    Great Plains Energy Incorporated - Strategy, SWOT and Corporate Finance Report Summary Great Plains Energy Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • MSCI Inc (MSCI):企業の財務・戦略的SWOT分析
    MSCI Inc (MSCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • China State Construction International Holdings Limited:戦略・SWOT・企業財務分析
    China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • Kingdom Hotel Investments:企業の戦略・SWOT・財務分析
    Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report Summary Kingdom Hotel Investments - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Gulf Oil Limited Partnership:企業の戦略的SWOT分析
    Gulf Oil Limited Partnership - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Versalis SpA:企業の戦略的SWOT分析
    Versalis SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆